Oxford Biolabs® is a nutraceutical and cosmeceutical company that develops a range of naturally-based products aimed at helping people avoid unwanted signs of ageing, such as hair loss, premature greying, and skin ageing. It was founded by scientists formerly of the University of Oxford under the leadership of Dr. Thomas Whitfield. Since 2009, the company has been pursuing the development and distribution of scientifically tested, drug-free nutraceutical products backed by world-class research.
Oxford Biolabs® has adopted a customer-oriented strategy that incorporates alternative natural therapies and ingredients. This bears no resemblance to the practice of some companies that prefer to limit their product range to drug-based formulas, which can often result in unwanted side effects.
Our premises are the epicentre of an innovative hub for our staff of professionals. The office space allows us to more efficiently design, develop, and deliver new nutraceuticals and cosmeceuticals in the field of hair loss, hair greying, skin ageing and ageing in general.
Oxford Biolabs is guided by corporate integrity and aims to be the world’s most innovative and well-respected nutraceutical and cosmeceutical company. We work on the latest scientific innovations and rely on continuous improvement which is ingrained in our culture. Our goal is to truthfully engage our customers with credible science and great products.
The Oxford Biolabs Team
Oxford Biolabs - In a Nutshell
"At Oxford Biolabs we are passionate about developing naturally based products aimed at helping people addressing the unwanted signs of ageing, such as hair loss"
- Dr. Thomas Whitfield, DPhil in Biochemistry from University of Oxford, UK
"At Oxford Biolabs we are aiming to provide the best possible products to our customers and the sole purpose of product development is to ensure this."
- Dr. Manfred Gahrtz, Dr. rer. nat. in Plant Biology from University of Regensburg, Germany.
Our Scientific Vision
Dr. Thomas Whitfield, DPhil
Dr. Manfred Gahrtz
Dr. Vira Polovska, PhD
Senior Product Development Manager
Dr. Umair Rafique
Medical Consultant and Sales Manager
Prof. Dr. Werner Kunz
Prof. Dr. Aris Xenaxis
Strategy & Communication
Organisational Development & HR
Watch interview with Prof. Werner Kunz
“I'm not only interested in basic science but also in bridging the gap between academic research and product development. In the field of the development of chemicals and anti-ageing products is where I can best take profit of my expertise in physical chemistry.”
- Professor Dr. Werner Kunz, Head of the Institute for Physical and Theoretical Chemistry, Chair of Department of Physical Chemistry, University of Regensburg (Germany)
“My research within the sphere of Biomimetics and Nanobiotechnology deals with studies of nanoformulations for encapsulating bio-active substances, and this research has led to applications in various sectors such as Pharmaceutics, Foods, and Cosmetics.”
- Professor Dr. Aristotelis Xenakis, Research Director at the Institute of Biology, Medicinal Chemistry & Biotechnology, National Hellenic Research Foundation
Watch interview with Prof. Aristotelis Xenakis
10,000 Small Businesses Alumni
Funded by Goldman Sachs and the Goldman Sachs Foundation
The Goldman Sachs 10,000 Small Businesses UK programme is designed to help small and medium sized enterprises create jobs and economic opportunity in the UK. The program also provides high-quality, practical education and business support to leaders of high-growth businesses and social enterprises across the country. The programme is run in partnership with the Said Business School at Oxford University, among others. In 2018 Oxford Biolabs has graduated from the program as one of 60 businesses of the program’s cohort 6. Read More
Ewing Marion Kauffman Foundation
Kansas City, Missouri, USA
San Jose, California, USA
Established in the mid-1960s by the late entrepreneur and philanthropist Ewing Marion Kauffman, the Kauffman Foundation is based in Kansas City, Missouri, and is among the largest private foundations in the United States with an asset base of approximately $2 billion. In 2009 Oxford Biolabs has been selected as one of 12 UK businesses to participate in the foundation’s 10-month “Kauffman Global Scholar Program”, where the company has been a resident at InCube Labs, a medical devices incubator in Silicon Valley. Read More
The UK's leading independent expert on innovation
National Endowment of Science, Technology and the Arts (NESTA) works with public, private and third-sector partners bringing together powerful combinations of people, resources and bright ideas. NESTA combines capital investment with non-financial support to help the UK's innovative companies turn their ideas into commercial success. In 2008 Oxford Biolabs has received a grant award through NESTA’s Flying Start fund.
National centre for entrepreneurship in education
Since its formation, NCEE has collaborated with many partners and organisations across the UK and internationally on a wide range of activities and projects. NCEE seeks to develop and promote a culture of entrepreneurship through research, education, and facilitation. In 2008 Oxford Biolabs has been selected as one of 12 UK businesses to receive support through NCEE’s Entrepreneurship Program.
Oxford Consulting Initiative
Oxford Student Foundation
The Oxford Consulting Initiative is a strategy consultancy providing services to Oxford-based companies. It aims to connect the pool of bright students interested in consulting and entrepreneurship with the growing start-up community in Oxford.
Strategic Consulting Project, Said Business School
University of Oxford
Since 2009 Oxford Biolabs has been a sponsoring organisation for the University of Oxford’s Said Business School’s Strategic Consulting Project, where MBA students undertake an eight-week consultancy project.